Back to Search Start Over

Grb2 inhibition: a new potential targeted therapy for myeloid malignancies?

Authors :
Etienne Paubelle
Xavier Thomas
Source :
The Lancet Haematology. 5:e128-e129
Publication Year :
2018
Publisher :
Elsevier BV, 2018.

Details

ISSN :
23523026
Volume :
5
Database :
OpenAIRE
Journal :
The Lancet Haematology
Accession number :
edsair.doi.dedup.....3dee0d44d456f9574f68e5cf29ebd488
Full Text :
https://doi.org/10.1016/s2352-3026(18)30031-0